NGLFINE.BO BSE

NGL Fine-Chem Limited operates as a global developer and purveyor of pharmaceutical products and chemical intermediates, catering to both the animal and human health industries. The company's extensive offerings include a broad spectrum of active pharmaceutical ingredients (APIs) for veterinary use, such as diminazene aceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine HCl, S-methoprene, praziquantel, toltrazuril, decoquinate, flunixin meglumine, carprofen, fenbendazole, amitraz, xylazine hydrochloride, and marbofloxacin. For human medical applications, they provide APIs like nitazoxanide and atovaquone. Furthermore, NGL Fine-Chem produces various intermediate compounds and specialized chemicals, alongside finished pharmaceutical preparations available in granular and tablet forms. This enterprise was founded in 1981 and has its principal operations located in Mumbai, India.